KOFI-ANN MCDERMOTT: Open Payments
NPI 1427821990 · LITHONIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,961 in 59 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $722 · 2025 $1,961
Food & beverage: $1,738Education: $223
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $233 |
| Janssen Biotech, Inc. | 6 | $223 |
| AstraZeneca Pharmaceuticals LP | 5 | $156 |
| JAZZ PHARMACEUTICALS INC. | 1 | $149 |
| Incyte Corporation | 3 | $148 |
| BeOne Medicines USA, Inc. | 2 | $140 |
| Eisai Inc. | 2 | $126 |
| ABBVIE INC. | 5 | $103 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| Genentech USA, Inc. | 4 | $87 |
Products named: SARCLISA, RYBREVANT, ZEPZELCA, BRUKINSA, Lenvima, Enhertu, Venclexta, LUPRON DEPOT.
Industry payments across GA — which companies pay providers there.
